Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: bob oserin who wrote (2625)	7/15/1999 10:43:00 PM
From: Debbie Wong	Read Replies (3) \| Respond to of 4676

Accumulate before 7/24! ISIP to get some attention. ===== Friday June 25, 2:10 pm Eastern Time Company Press Release 'All-Star' Analyst Craig Parker of DLJ To Keynote Seventh Informed Investors SF Bay Biotech Stocks Forum July 24 BERKELEY, Calif.--(BUSINESS WIRE)--June 25, 1999--Will the 1990s end as the ''Bio-Bust Decade'' or will a late flurry on the upside propel this long-maligned sector back into favor? Even with recent strength, is this a ''Bio-Bubble'' or the beginning of a real advance? Investors interested in the biosciences will get a full current look at the sector at the Seventh Informed Investors SF Bay Biotechnology Stocks Forum Saturday morning July 24 at the Marina Radisson in Berkeley. The Forum runs from 8:30-1 p.m. Cost is $25 prepaid, $40 at the door. Register at www.informedinvestors.com or call 800/992-4683. ''The biotech sector requires careful scrutiny because it's difficult to separate the risks from the rewards,'' said Tim Quast, President of Informed Investors Forum, organizer of the conference. ''This is a key Forum among the ten or so biotech events we do each year because it precurses the autumn conference season when many companies make announcements. The sector's brimming with exciting developments that have been overshadowed by investor-obsession with Internet stocks.'' Keynote speaker Craig Parker is vice president and senior technology analyst at Donaldson Lufkin Jenrette and will share his latest thinking and analysis with investors. Senior management from biotech companies will update investors as well. Companies scheduled thus far are Isis Pharmaceuticals (Nasdaq:ISIP - news), Aradigm (Nasdaq:ARDM - news), Corvas (Nasdaq:CVAS - news), Ribozyme Pharmaceuticals (Nasdaq:RYZM - news), Inhale Therapeutics (Nasdaq:INHL - news) and Advanced Tissue Sciences (Nasdaq:ATIS - news). Prior to joining DLJ, Parker was at J.P. Morgan where he was the senior biotechnology analyst for four years. In 1997, Parker was named to the Wall Street Journal's All Star Analyst Team in the biotechnology sector and was ranked by Institutional Investor Magazine as best ''up and comer'' in the biotech sector. Parker's coverage at DLJ includes Alkermes (Nasdaq:ALKS - news), Amgen (Nasdaq:AMGN - news), Centocor (Nasdaq:CNTO - news), Chiron (Nasdaq:CHIR - news), Gilead Sciences (Nasdaq:GILD - news), Immunex (Nasdaq:IMNX - news), Invitrogen (Nasdaq:IVGN - news) and Transkaryotic Therapies (Nasdaq:TKTX - news). Sacramento-based Informed Investors Forum is the leading producer of industry-specific investment conferences for individual investors and has featured hundreds of quality companies and scores of industry experts at its Forums. Each year, more than 20,000 investors, who control an estimated $5 billion in investable assets, attend the Forums onsite and via the Internet.